Search
Acetylcysteine
go.drugbank.com/drugs/DB06151ApprovedInvestigational[A228158,A228163,A228168] Acetylcysteine was granted FDA approval on 14 September 1963.[L31488] … Acetylcysteine is an antioxidant and glutathione inducer indicated for mucolytic therapy and the treatment of [acetaminophen] overdose.
Mixtures: AMINOPLASMAL-10% E INFUSION, AMINOPLASMAL-5% E INFUSIONCategories: Compounds used in a research, industrial, or household settingIcatibant
go.drugbank.com/drugs/DB06196ApprovedInvestigationalrelief was observed to be 8 hours compared to 36 hours for the placebo treatment. … [A4017,A263046] Icatibant was approved by the FDA on August 25, 2011, and by the EMA in 2008 as a treatment for hereditary angioedema.
Categories: Drugs Used in Hereditary AngioedemaProducts: Icatibant Reddy 30 mg/3 ml Injektionslösung in einer Fertigspritze, Icatibant STADA 30 mg Injektionslösung in einer FertigspritzeFlupentixol
go.drugbank.com/drugs/DB00875ApprovedInvestigationalWithdrawnFlupentixol is an antipsychotic drug of the thioxanthene group. It exists in two geometric isomers, the trans(E) and pharmacologically active cis(Z) forms. … It is approved for use in Canada and other countries around the world, but not in the US.
Mixtures: DORMIR TABLET, 20 ADETProducts: FLUANXOL DEPOT 20MG/ML IM ENJ. SOLUSYON, 1 ADET, FLUANXOL DEPOT INJECTION 20 mg/mlAdenosine
go.drugbank.com/drugs/DB00640ApprovedInvestigational[A229833,A229838] Adenosine is also indicated in the treatment of supraventricular tachycardia.[L31998] Adenosine was granted FDA approval on 30 October 1989.[L31978] … [A229828] Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy,[L31983] though it is rarely used in this indication, having largely been replaced by [dipyridamole]
Mixtures: Propolis 80, Centella 80 EyeProducts: ADENOSIN-L.M. 5 MG/ML ENJ/INF. ICIN COZ. ICEREN 10 ML 10 FLAKON, ADENOSIN-L.M. 5 MG/ML ENJ/INF. ICIN COZ. ICEREN 50 ML 10 FLAKONClindamycin
go.drugbank.com/drugs/DB01190ApprovedInvestigationalVet approvedThe name lincomycin is derived from Lincoln, Nebraska, where it was first isolated from _Streptomyces lincolnensis_ found in a soil sample.[A190621] … [A190621] Interestingly, clindamycin appears to carry some activity against protozoans, and has been used off-label in the treatment of toxoplasmosis, malaria, and babesiosis.
Mixtures: OXIMIN 10 MG/G + 50 MG/G JEL,50 G, OXIMIN 10 MG/G + 50 MG/G JEL,25 GProducts: CLINDAMCINA INFUSION 600 MG EN DEXTROSA AL 5 % POR 100 ML, MENEKLIN 300 MG/2 ML ENJEKSİYONLUK ÇÖZELTİ, 50 ADETFingolimod
go.drugbank.com/drugs/DB08868ApprovedInvestigationalMultiple sclerosis, or MS, is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects. … It was developed by Novartis and initially approved by the FDA in 2010.[L12651] Fingolimod was also studied for the treatment of COVID-19, the disease caused by infection with the SARS-CoV-2 virus.
Products: FINGOLIMOD EG, FİGOFİN 0.5 MG KAPSÜL, 30 ADETSodium chloride
go.drugbank.com/drugs/DB09153ApprovedInvestigationalVet approvedSodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines. … Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions.
Mixtures: SOLUCION DP PISA 2.5%(MODIFICADA EN MAGNESIO Y LACTATO), PISAProducts: SOLUCIÓN CS PISA, CLORURO DE SODIO AL 0.9% EN AGUA INYECTABLESolifenacin
go.drugbank.com/drugs/DB01591ApprovedInvestigational[L7511] Solifenacin was granted FDA approval on 19 November 2004.[L7511] … Solifenacin is a competitive muscarinic receptor antagonist indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.
Mixtures: VESOMNİ 6 MG/0.4 MG DEĞİŞTİRİLMİŞ SALIMLI TABLET, 30 ADET, Vesomni 6 mg/0,4 mg Tabletten mit veränderter WirkstofffreisetzungCategories: Drugs Used in Benign Prostatic HypertrophyBisacodyl
go.drugbank.com/drugs/DB09020ApprovedInvestigational[A233290,A233300,A207700] Bisacodyl was patented on 25 September 1956[L33045] but has been used as a laxative since 1952.[A233300]
Mixtures: BEKUNIS 3 MG/5 MG KAPLI TABLET, 30 ADETProducts: Soflax EX 10, Ag-bisacodyl ECLacidipine
go.drugbank.com/drugs/DB09236ApprovedIn randomised, well-controlled trials, administration of daily single-dose lacidipine ranging from 2-6 mg demonstrated comparable antihypertensive efficacy similar to that of other long-acting dihydropyridine … It is available as once-daily oral tablets containing 2 or 4 mg of the active compound commonly marketed as Lacipil or Motens. It is not currently FDA-approved.
Products: LACIDIPINA EG, LACIPIL TABLET 4 mg